NEONC TECHNOLOGIES HOLDINGS, INC. APIC, Share-based Payment Arrangement, Increase for Cost Recognition
NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $5.65 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Shareholders' Equity
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-08-10
- NEONC TECHNOLOGIES HOLDINGS, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-06-30 was $5.65M, a 60.29% increase year-over-year.
- NEONC TECHNOLOGIES HOLDINGS, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-03-31 was $2.73M, a 84.29% decline year-over-year.
- NEONC TECHNOLOGIES HOLDINGS, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-09-30 was $5.04M.
- NEONC TECHNOLOGIES HOLDINGS, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-06-30 was $3.53M.
- NEONC TECHNOLOGIES HOLDINGS, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2025 was $35.56M.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month as first filed | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $5.65M 10-Q · filed 2026-08-10 | $8.38M derived: sum of 2 quarters · filed 2026-08-10 | |||
| 2026-03-31 | $2.73M 10-Q · filed 2026-08-10 | ||||
| 2025-12-31 | $35.56M 10-K · filed 2026-03-31 | ||||
| 2025-09-30 | $5.04M 10-Q · filed 2025-11-14 | $8.57M derived: sum of 2 quarters · filed 2026-08-10 | $25.96M derived: sum of 3 quarters · filed 2026-08-10 | ||
| 2025-06-30 | $3.53M 10-Q · filed 2026-08-10 | $20.92M derived: sum of 2 quarters · filed 2026-08-10 | |||
| 2025-03-31 | $17.40M 10-Q · filed 2026-08-10 | $23.07M 10-Q · filed 2025-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 | |
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |